Latest return on equity
Ligand Pharmaceuticals Return on equity
Direct answer
Ligand Pharmaceuticals's return on equity is 21.96%.
The verified market snapshot reports 21.96%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 7, 2026.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 21.96%
Explore related company data
View Ligand Pharmaceuticals's market capitalizationView Ligand Pharmaceuticals's p/e ratioView Ligand Pharmaceuticals's price-to-book ratioView Ligand Pharmaceuticals's 52-week price rangeView Ligand Pharmaceuticals's revenue growthView Ligand Pharmaceuticals's profit marginView Ligand Pharmaceuticals's debt-to-equity ratioView all Ligand Pharmaceuticals key metricsReturn to Ligand Pharmaceuticals profile